LEAD PARTNER
Leveragen
Leveragen is a Boston-based genetic engineering company developing next-generation mouse
models for antibody discovery. Leveragen’s flagship platform, the Singularity Sapiens mouse, exclusively generates heavy chain antibodies from the complete human VH repertoire integrated
into the modified mouse Igh locus. This targeted approach safeguards gene regulation and abolishes interference from conventional antibodies, promoting optimal B cell development and robust immune responses. Consequently, the derived single-domain antibodies exhibit superior diversity, affinity, stability, solubility, modularity, and functionality.
PROGRAM PARTNERS
Certara
Certara accelerates medicines using proprietary biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Cytiva
Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics—from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
ImmunoPrecise Antibodies
IPA (ImmunoPrecise Antibodies) is redefining biotherapeutic technology and research. We lead in
antibody discovery and development with decades of expertise and four cutting-edge R&D sites, partnering with 19 of the top 20 pharmaceutical companies. Our AI-driven in silico capabilities, in
vivo and in vitro technologies, and LENSai™ technology accelerate drug discovery while reducing risks, time, and costs. As the Hub of Biotherapeutic Intelligence, we offer customizable, end-toend capabilities, driving novel biologic breakthroughs globally.
OmniAb
OmniAb’s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of nextgeneration therapeutics. At the heart of the OmniAb platform is the Biological Intelligence™ (BI) of our proprietary transgenic animals, including OmniRat®, OmniChicken® and OmniMouse® that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic® (transgenic rat) and Amnicolid® (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets.
INNOVATION PARTNERS
BSP Pharmaceuticals
BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a specific focus on innovative compounds as small and large molecules. With full containment facility, applying the most advanced and safe technologies, BSP can offer a wide range of services for Pre-Clinical, Clinical and Commercial supply in compliance with the highest Quality requirements.
Evitria
Evitria AG is a Swiss-based global leader in transient expression and purification services of antibodies and proteins. We provide expert guidance in bispecific and multispecific development with HT screening production, optimized purification approaches, and novel technologies to explore. Our fourteen-year history with >130,000 successful protein production runs highlights a rapid and reliable platform, and we are excited to share this with the community in-person at World Bispecifics 2024.
NONA Bio
Nona Biosciences is a Boston-based Biotech company specialized in fully human therapeutic antibody technology. Our proprietary Harbour Mice® technology are fully human transgenic mice platforms for either conventional fully human antibody (H2L2) or heavy chain only (HCAb) antibody discovery, engineering, and development. The HCAb platform is fully optimized and clinically validated with global patented protection.
SVAR
Svar offers a unique combination of scientific expertise, high-quality products, strong services,
and proprietary technology platforms, providing a flexible, effective, and seamless experience
for customers. As experts in cell engineering and advanced cell-based assay development, we
provide the iLite® technology and tailored services, helping clients navigate complex hurdles with
confidence and propelling advancements in their drug development journey.
EXHIBITION PARTNER
Biointron
Founded in 2012 and ISO 9001:2015 certified, Biointron is a CRO specializing in antibody discovery, expression, and optimization for biotech and pharmaceutical companies. Biointron leads in antibody expression services. From gene sequence to purified antibodies, our production only takes 2 weeks. We have delivered antibodies to over 1,500 biotech and pharma companies worldwide. Contact us at +1 (732) 790-8340 | info@biointron.com
Creative Biolabs
Technical advancement has always been a focus of Creative Biolabs, which, sustained by seasoned scientists and cutting-edge methodologies, provides technical support for global customers in the academic and industrial sectors with market-pioneering solutions especially for bispecific antibody (BsAb) discovery, covering BsAb antibody design, purification, engineering, analysis, as well as top-tier BsAb products such as appended IgGs, tandem scFv, bispecific IgGs, diabody, and minibody. Featured and exclusive platforms incorporating hybridoma, chemical conjugation, and genetic engineering are the driving force behind the success of assorted projects.
Cyagen
Cyagen is a global leader in genetically modified rodent models and cell and gene therapy (CGT) R&D. With 17+ years of experience, we provide one-stop solutions for disease model development, AAV discovery, drug efficacy studies, and more. Our "AI+CGT" platform accelerates CGT research, offering diverse KO/cKO mouse strains in our Knockout Catalog Models. We specialize in customized models via CRISPR-Pro, TurboKnockout, and transgenic tech. Our Rare Disease Data Center (RDDC) supports rare disease research with AI-driven bioinformatics tools. Trust Cyagen for cutting-edge gene therapy and drug development research worldwide.
Nicoya
Nicoya is a Canadian life sciences tools company specializing in innovative biosensor technology for the academic, biotechnology and pharmaceutical sectors. Their Alto™ digital SPR platform is the first of its kind, integrating digital microfluidics and surface plasmon resonance technologies
to create the world’s friendliest SPR system. With a flexible 16-channel design, 2 μL sample requirements, automated sample preparation, and one-click analysis, Alto takes you from sample
to answer within hours and equips your team with high-quality data to accelerate biotherapeutic development.
RESEARCH PARTNER
Beacon
We are a competitive and research intelligence database solution designed in partnership with pharmaceutical professionals across the world. We work in targeted therapies such as bispecific antibodies
to provide accurate, in-depth, and real-time information in the rapidly evolving landscape of drug development. Find out how we can accelerate your drug development program by visiting our website.